Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
India · Delayed Price · Currency is INR 24.00
-0.06 (-0.25%)
At close: May 8, 2026
BOM:531015 Market Cap
BOM:531015 has a market cap or net worth of 277.99 million as of May 8, 2026. Its market cap has increased by 82.60% in one year.
Market Cap
277.99M
Enterprise Value
296.93M
Revenue
44.14M
Ranking
n/a
PE Ratio
17.47
Stock Price
24.00
Market Cap Chart
Since April 15, 2008, BOM:531015's market cap has increased from 32.40M to 277.99M, an increase of 758.02%. That is a compound annual growth rate of 12.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 277.99M | 112.68% |
| Dec 31, 2025 | 130.71M | 38.30% |
| Dec 31, 2024 | 94.51M | 357.87% |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tyche Industries | 1.38B |
| Smruthi Organics | 1.38B |
| Krebs Biochemicals & Industries | 1.29B |
| Resonance Specialties | 1.26B |
| Bacil Pharma | 810.80M |
| Alfavision Overseas (India) | 418.35M |
| Vasundhara Rasayans | 415.87M |
| Crestchem | 371.70M |